Clinical Trials List
Protocol NumberKN-8701
2022-01-01 - 2025-12-31
Phase I
Recruiting3
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 徐偉勛 無
- CHAO-CHI HO CHAO-CHI HO 無
- 楊景堯 無
- YEN-TING LIN 無
- 廖斌志 無
- 廖唯昱 無
- 吳尚俊 無
- James Chih-Hsin Yang 無
- JIN-YUAN SHIH 無
- 許嘉林 無
- Jih-Hsiang Lee 無
- Chong-Jen Yu 無
- 蔡子修 無
- 林昭文 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Mu-Hsin Chang 無
- 許志堅 無
- San-Chi Chen 無
- 林泰祺 無
- Tien-Hua Chen 無
- 姜乃榕 無
- Ming-Huang Chen 無
- Yi-Ping Hung 無
- Chien-An Liu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
262 participants
